108 related articles for article (PubMed ID: 20061610)
1. Increased activity of mitochondrial aldehyde dehydrogenase (ALDH) in the putamen of individuals with Alzheimer's disease: a human postmortem study.
Michel TM; Gsell W; Käsbauer L; Tatschner T; Sheldrick AJ; Neuner I; Schneider F; Grünblatt E; Riederer P
J Alzheimers Dis; 2010; 19(4):1295-301. PubMed ID: 20061610
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
3. Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease.
Aliev G; Palacios HH; Walrafen B; Lipsitt AE; Obrenovich ME; Morales L
Int J Biochem Cell Biol; 2009 Oct; 41(10):1989-2004. PubMed ID: 19703659
[TBL] [Abstract][Full Text] [Related]
4. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease.
Reddy PH
J Neurochem; 2006 Jan; 96(1):1-13. PubMed ID: 16305625
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates.
Daiber A; Oelze M; Coldewey M; Bachschmid M; Wenzel P; Sydow K; Wendt M; Kleschyov AL; Stalleicken D; Ullrich V; Mülsch A; Münzel T
Mol Pharmacol; 2004 Dec; 66(6):1372-82. PubMed ID: 15331769
[TBL] [Abstract][Full Text] [Related]
6. Oxidative modification of proteins in the frontal cortex of Alzheimer's disease brain.
Korolainen MA; Goldsteins G; Nyman TA; Alafuzoff I; Koistinaho J; Pirttilä T
Neurobiol Aging; 2006 Jan; 27(1):42-53. PubMed ID: 16298240
[TBL] [Abstract][Full Text] [Related]
7. Nitrate reductase activity of mitochondrial aldehyde dehydrogenase (ALDH-2) as a redox sensor for cardiovascular oxidative stress.
Daiber A; Münzel T
Methods Mol Biol; 2010; 594():43-55. PubMed ID: 20072908
[TBL] [Abstract][Full Text] [Related]
8. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease.
Bartzokis G; Tishler TA
Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):821-33. PubMed ID: 10875443
[TBL] [Abstract][Full Text] [Related]
9. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease.
Mecocci P; MacGarvey U; Beal MF
Ann Neurol; 1994 Nov; 36(5):747-51. PubMed ID: 7979220
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial oxidative stress index, activity of redox-sensitive aconitase and effects of endogenous anti- and pro-oxidants on its activity in control, Alzheimer's disease and Swedish Familial Alzheimer's disease brain.
Raukas M; Rebane R; Mahlapuu R; Jefremov V; Zilmer K; Karelson E; Bogdanovic N; Zilmer M
Free Radic Res; 2012 Dec; 46(12):1490-5. PubMed ID: 22962855
[TBL] [Abstract][Full Text] [Related]
11. Aldehyde dehydrogenase 2 in sporadic Parkinson's disease.
Michel TM; Käsbauer L; Gsell W; Jecel J; Sheldrick AJ; Cortese M; Nickl-Jockschat T; Grünblatt E; Riederer P
Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S68-72. PubMed ID: 24262192
[TBL] [Abstract][Full Text] [Related]
12. Chronically increased oxidative stress in fibroblasts from Alzheimer's disease patients causes early senescence and renders resistance to apoptosis by oxidative stress.
Naderi J; Lopez C; Pandey S
Mech Ageing Dev; 2006 Jan; 127(1):25-35. PubMed ID: 16188294
[TBL] [Abstract][Full Text] [Related]
13. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease.
Wang J; Xiong S; Xie C; Markesbery WR; Lovell MA
J Neurochem; 2005 May; 93(4):953-62. PubMed ID: 15857398
[TBL] [Abstract][Full Text] [Related]
14. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease.
Marcus DL; Thomas C; Rodriguez C; Simberkoff K; Tsai JS; Strafaci JA; Freedman ML
Exp Neurol; 1998 Mar; 150(1):40-4. PubMed ID: 9514828
[TBL] [Abstract][Full Text] [Related]
15. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
Abdul HM; Calabrese V; Calvani M; Butterfield DA
J Neurosci Res; 2006 Aug; 84(2):398-408. PubMed ID: 16634066
[TBL] [Abstract][Full Text] [Related]
16. Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer's disease.
Polidori MC; Griffiths HR; Mariani E; Mecocci P
Amino Acids; 2007; 32(4):553-9. PubMed ID: 17273806
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial aging and dysfunction in Alzheimer's disease.
Sullivan PG; Brown MR
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Mar; 29(3):407-10. PubMed ID: 15795049
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial abnormalities in Alzheimer brain: mechanistic implications.
Bubber P; Haroutunian V; Fisch G; Blass JP; Gibson GE
Ann Neurol; 2005 May; 57(5):695-703. PubMed ID: 15852400
[TBL] [Abstract][Full Text] [Related]
19. Enhanced ROS-generation in lymphocytes from Alzheimer's patients.
Leutner S; Schindowski K; Frölich L; Maurer K; Kratzsch T; Eckert A; Müller WE
Pharmacopsychiatry; 2005 Nov; 38(6):312-5. PubMed ID: 16342003
[TBL] [Abstract][Full Text] [Related]
20. PAN-811 inhibits oxidative stress-induced cell death of human Alzheimer's disease-derived and age-matched olfactory neuroepithelial cells via suppression of intracellular reactive oxygen species.
Nelson VM; Dancik CM; Pan W; Jiang ZG; Lebowitz MS; Ghanbari HA
J Alzheimers Dis; 2009; 17(3):611-9. PubMed ID: 19433896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
